Default company panoramic image

Liverpool School of Tropical Medicine

HexaGardTM: a new drug to replace intravenous immunoglobulin (IVIG) to control inflammation in autoimmune disease

  • Stage Concept Only
  • Industry Biotechnology
  • Location Liverpool, GB-ENG, United Kingdom
  • Currency USD
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.